U.S. markets open in 1 hour 38 minutes
  • S&P Futures

    3,227.50
    -3.75 (-0.12%)
     
  • Dow Futures

    26,671.00
    -14.00 (-0.05%)
     
  • Nasdaq Futures

    10,790.50
    -38.50 (-0.36%)
     
  • Russell 2000 Futures

    1,451.90
    +5.20 (+0.36%)
     
  • Crude Oil

    39.99
    +0.06 (+0.15%)
     
  • Gold

    1,861.50
    -6.90 (-0.37%)
     
  • Silver

    22.42
    -0.69 (-2.99%)
     
  • EUR/USD

    1.1641
    -0.0020 (-0.17%)
     
  • 10-Yr Bond

    0.6760
    0.0000 (0.00%)
     
  • Vix

    29.02
    +2.16 (+8.04%)
     
  • GBP/USD

    1.2733
    +0.0007 (+0.05%)
     
  • USD/JPY

    105.4280
    +0.0960 (+0.09%)
     
  • BTC-USD

    10,419.22
    +169.75 (+1.66%)
     
  • CMC Crypto 200

    220.81
    +6.84 (+3.20%)
     
  • FTSE 100

    5,893.14
    -6.12 (-0.10%)
     
  • Nikkei 225

    23,087.82
    -258.67 (-1.11%)
     

Apyx Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Apyx Medical Corporation To Contact The Firm

Newsfile Corp.

New York, New York--(Newsfile Corp. - March 19, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Apyx Medical Corporation (NASDAQ: APYX) ("Apyx" or the "Company").



Faruqi & Faruqi logo

If you invested in Apyx stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/APYX. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53586